STOCK TITAN

Weiss Asset Management and Andrew Weiss report 5.7% stake in AIV (AIV)

(Moderate)
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Apartment Investment & Management Co. Schedule 13G reports that Weiss Asset Management, WAM GP LLC and Andrew M. Weiss beneficially own 8,150,456 shares of Class A Common Stock, equal to 5.7% of the class. The filing cites 143,870,326 Class A shares outstanding as of February 27, 2026.

The filing lists shared voting and dispositive power over the reported shares and is signed by an authorized signatory on May 11, 2026.

Positive

  • None.

Negative

  • None.
Reported shares beneficially owned 8,150,456 shares Beneficial ownership reported on Schedule 13G
Percent of class 5.7% Calculated using shares outstanding as of <date>February 27, 2026</date>
Class A shares outstanding 143,870,326 shares As of <date>February 27, 2026</date>, per issuer Form 10-K
CUSIP 03748R747 Class A Common Stock CUSIP reported on the filing
Filing signature date May 11, 2026 Signature date on Schedule 13G
Schedule 13G regulatory
"Schedule 13G reports beneficial ownership of securities"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
beneficially owned financial
"Amount beneficially owned: 8,150,456"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared dispositive power regulatory
"Shared Dispositive Power 8,150,456.00"
joint filing agreement legal
"Exhibit Information Joint Filing Agreement"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What stake does Weiss Asset Management report in AIV?

Weiss Asset Management reports 8,150,456 shares (5.7%) of AIV Class A Common Stock. The filing shows shared voting and dispositive power for that aggregate position reported by Weiss Asset Management, WAM GP LLC and Andrew M. Weiss.

How was the 5.7% ownership calculated for AIV (AIV)?

The 5.7% figure is based on 143,870,326 Class A shares outstanding as of February 27, 2026, per the issuer's Form 10-K. The Schedule 13G cites that share count when computing percent of class.

Who are the filers listed on the Schedule 13G for AIV?

The filing names Weiss Asset Management LP, WAM GP LLC, and Andrew M. Weiss with a shared business address in Boston. WAM GP is the general partner and Andrew Weiss is the managing member; each disclaims beneficial ownership except to the extent of pecuniary interest.

When was the AIV Schedule 13G signed and who signed it?

The Schedule 13G was signed on May 11, 2026 by Mary Merrigan as Authorized Signatory and as Attorney-in-Fact for Andrew M. Weiss, under a referenced power of attorney incorporated by exhibit reference.





03748R747

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Weiss Asset Management LP
Signature:Mary Merrigan
Name/Title:Authorized Signatory
Date:05/11/2026
WAM GP LLC
Signature:Mary Merrigan
Name/Title:Authorized Signatory
Date:05/11/2026
WEISS ANDREW M
Signature:Mary Merrigan
Name/Title:Attorney-in-Fact for Andrew M. Weiss***
Date:05/11/2026

Comments accompanying signature: ***Duly authorized under Power of Attorney incorporated herein by reference to the exhibit to the Form 13G/A filed by Weiss Asset Management LP on February 3, 2023 in respect of its holding in DEEP MEDICINE ACQUISITION CORP.
Exhibit Information

Joint Filing Agreement